One of the most common antidepressants, sertraline, contributes to a modest improvement in core depression and anxiety symptoms, within two weeks, finds a new analysis of a major clinical trial led by Dr Giulia Piazza (UCL Psychiatry & UCL Psychology & Language Sciences).
Read: The BMJ, UCL News
Close
